Top compounds associated with response to TSFM


Feature Type Standardized
Nominal ANOVA
mRNA XL-184 GDSC1000 pan-cancer AAC -0.038 0.2
mRNA PDMP CTRPv2 pan-cancer AAC -0.043 0.2
mRNA ML162 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.087 0.3
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.087 0.3
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.031 0.3
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.04 0.3
Download CSV